Quality assurance program plan for Building 324

This Quality Assurance Program Plan (QAPP) provides an overview of the quality assurance program for Building 324. This plan supersedes the PNNL Nuclear Facilities Quality Management System Description, PNL-NF-QMSD, Revision 2, dated March 1996. The program applies to the facility safety structures, systems, and components and to activities that could affect safety structures, systems, and components. Adherence to the quality assurance program ensures the following: US Department of Energy missions and objectives are effectively accomplished; Products and services are safe, reliable, and meet or exceed the requirements and expectations of the user; Hazards to the public, to Hanford Site and facility workers, and to the environment are minimized. The format of this Quality Assurance Program Plan is structured to parallel that of 10 CFR 83 0.120, Quality Assurance Requirements

Performance of the ECR ion source of CERN's heavy ion injector

In fall 1994 the new heavy ion injector at CERN was brought into operation successfully and a lead beam of 2.9´107 ions per pulse was accelerated in the SPS up to an energy of 157 GeV/u. The ion source, which was supplied by GANIL (France) was in operation almost continuously over a period of about one year and proved to be very reliable. It pro-duces a current of more than 100 µA of Pb27+ (after the first spectrometer) during the afterglow of the pulsed discharge. The current stays within 5% of the maximum value for a time of about 1 ms, which is more than required by the accel-erators. Measurements of the charge state distribution, emittance and energy spread, which were made during this window, are presented together with other operating data

Modeling hospital infrastructure by optimizing quality, accessibility and efficiency via a mixed integer programming model

BACKGROUND: The majority of curative health care is organized in hospitals. As in most other countries, the current 94 hospital locations in the Netherlands offer almost all treatments, ranging from rather basic to very complex care. Recent studies show that concentration of care can lead to substantial quality improvements for complex conditions and that dispersion of care for chronic conditions may increase quality of care. In previous studies on allocation of hospital infrastructure, the allocation is usually only based on accessibility and/or efficiency of hospital care. In this paper, we explore the possibilities to include a quality function in the objective function, to give global directions to how the ‘optimal’ hospital infrastructure would be in the Dutch context. METHODS: To create optimal societal value we have used a mathematical mixed integer programming (MIP) model that balances quality, efficiency and accessibility of care for 30 ICD-9 diagnosis groups. Typical aspects that are taken into account are the volume-outcome relationship, the maximum accepted travel times for diagnosis groups that may need emergency treatment and the minimum use of facilities. RESULTS: The optimal number of hospital locations per diagnosis group varies from 12-14 locations for diagnosis groups which have a strong volume-outcome relationship, such as neoplasms, to 150 locations for chronic diagnosis groups such as diabetes and chronic obstructive pulmonary disease (COPD). CONCLUSIONS: In conclusion, our study shows a new approach for allocating hospital infrastructure over a country or certain region that includes quality of care in relation to volume per provider that can be used in various countries or regions. In addition, our model shows that within the Dutch context chronic care may be too concentrated and complex and/or acute care may be too dispersed. Our approach can relatively easily be adopted towards other countries or regions and is very suitable to perform a ‘what-if’ analysis

Controlling Silver Nanoparticle Size and Morphology with Photostimulated Synthesis

Photo-induced synthesis and control over the size and shape of colloidal silver nanoparticles is investigated in contrast to photo-stimulated aggregation of small nanoparticles into large fractal-type structures. The feasibility of light-driven nanoengineering which enables manipulation of the sizes and shapes of the isolated nanoparticles is studied by varying the amount and type of the stabilizing agent and the type of optical irradiation.Comment: 10 pages, 7 figures, 11 image

Operational experience with the CERN hadron linacs

The present CERN proton linac (Linac2) was commissioned in 1978 and since that date has been the primary source of protons to the CERN accelerator complex. During the past 18 years, the machine has had a very good reliability record in spite of the demands made upon it. Modifications have been made with the view of maintaining this reliability with reduced resources and new requirements from the users. Further demands will be made in the future for LHC operation. In 1994, a new linac for heavy ion production was put into service replacing the original CERN proton linac. As this machine was built within an international collaboration, operation had to take into account the novelty of the techniques used and the variety of equipment supplied by outside collaborators. Even so, the new machine has also had very good reliability

Experimental investigation of electron cooling and stacking of lead ions in a low energy accumulation ring

This report gives the results of a programme of experimental investigations, which were carried out to test stacking of lead ions in a storage ring (the former Low Energy Antiproton Ring, LEAR) at 4.2 MeV per nucleon. The motivation was to demonstrate the feasibility of gaining the large factor in the phase-space density required for injection into the LHC. In the first part of the report, the layout of the experiments is described, the choice of the parameters of the electron cooling system used for stacking is reported and the multi-turn injection using horizontal- and longitudinal- (and in the final project also vertical-) phase space is discussed. In the second part the experimental results are presented. Factors of vital importance are the stacking efficiency, the beam life-time and the cooling time of the ions. The beam decay owing to charge exchange with the residual gas and to recombination by the capture of cooling electrons was intensively studied. Beam instabilities and space-charge effects in the ion beam turned out to be additional, although less serious, limitations of the accumulation rate. The cooling speed as a function of cooler and storage-ring properties was investigated over a wide range of parameters. Among the 'surprises' encountered are an anomalously fast recombination rate for certain ion charge states (Pb53+), a strong dependence of the cooling time on the dispersion function of the storage ring, and an intensity-dependent outgassing of equipment in the vacuum chamber. After a careful choice of parameters and antidotes, an overall factor of 120 in intensity could be gained, by multi-turn injection and stacking for 4 s. The intensity obtained ($6 x 10^8$ ions with a length corresponding to four LHC bunches) is only a factor of two short of the LHC requirement, and the stacking time (4 s instead of 2 s foreseen for filling each LHC ring in 8 min) is another factor of two off

1,2-Bis{bis­[4-(trifluoro­meth­yl)phen­yl]phosphino}ethane

Crystals of the title compound, C30H20F12P2 or R 2PCH2CH2PR 2 (R = 4-C6H4CF3), were inadvertently prepared while attempting to recrystallize a crude sample of trans-Re(Cl)(N2)(R 2PCH2CH2PR 2)2 from diethyl ether. The molecule lies on a center of inversion. One of the rings lies approximately in the P—C—C—P plane; the dihedral angle is 174.53°.The other ring is not quite perpendicular; the dihedral angle is 71.1°. The compound is isostructural with the R = Ph, 4-C6H4CH3 and 4-C6H4CH2CH3 analogues. It is well known that the basicity of phosphines and diphosphines can be altered by changing the electron-donating ability of R; however, the structural parameters for the title compound do not significantly differ from those of the aforementioned substituted-phenyl compounds